What You Should Know:
– Ultromics, a pioneer in AI-driven cardiology solutions secures $55M in Series C financing co-led by L&G, Allegis Capital, and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture…
Continue Reading
Oxford Science Enterprises (OSE) and Cedars-Sinai Intellectual Property Company announced a partnership to support health-tech startups expanding from the United Kingdom to the United States.The collaboration will provide funding, resources and market access to…
Continue Reading
British company Ultromics has been granted FDA Breakthrough Device Status for its artificial intelligence (AI)-enhanced platform for detecting cardiac amyloidosis.EchoGo Amyloidosis uses AI technology to analyse echocardiograms to detect the presence of cardiac amyloidosis….
Continue Reading
